Over the course of 2023, the medtech industry produced another impressive year of innovation, with news coming from a variety of spaces. Chiefly among those were diabetes technologies and in vitro diagnostics (IVDs). We saw regulatory nods, product launches, funds raised and mergers fall apart. Looking at those two spaces in particular, here are five […]
Cytovale
Cytovale raises $84M Series C for sepsis diagnostic
Cytovale announced today that it raised $84 million in a Series C funding round to support its rapid sepsis diagnosis test. San Francisco-based Cytovale plans to use the funds to further expand the reach of its FDA-cleared IntelliSep sepsis test. The FDA cleared IntelliSep, which aids hospital emergency departments and health systems, in January. IntelliSep […]
FDA clears new sepsis diagnostic from Cytovale
Cytovale announced today that it received FDA 510(k) clearance for its IntelliSep test for the early detection of sepsis. San Francisco-based Cytovale designed IntelliSep to provide test results in under 10 minutes. The emergency department-focused tool helps clinicians recognize sepsis and make time-sensitive critical decisions. It provides actionable answers directly from a standard blood draw. […]
